Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Living with a COVID-19 case brings worse symptoms and stronger antibody response

This study suggests that high virus exposure levels contribute to greater disease severity and stronger antibody responses. The observations from this study are published on the medRxiv preprint server.

17 Mar 2021

SARS-CoV-2 can spread through cold-chain transport

In light of growing evidence, researchers say that SARS-CoV-2 virus transmission via contaminated surfaces, and in particular, frozen foods and products that are transported while keeping them at low temperatures, should be taken into account when devising prevention strategies.

16 Mar 2021

Using iodine as catalyst to advance the sustainability of pharmaceutical syntheses

Synthesizing pharmaceuticals for cancer, viral diseases, and other medical conditions is slow work. A particularly challenging chemical transformation is to start with what's known as an unactivated alkene--a common molecular building block--and end up with a vicinal diamine; i.e., installation of two nitrogen units into carbon--carbon double bonds.

16 Mar 2021

Combination therapy may reduce influenza-associated morbidity and mortality

A significant proportion of hospitalized patients with influenza develop complications of acute respiratory distress syndrome, driven by virus-induced cytopathic effects as well as exaggerated host immune response.

16 Mar 2021

Ferret study shows SARS-CoV-2 airborne transmission dynamics

A team of researchers led by Sander Herfst from Erasmus University Medical Center in The Netherlands suggests severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could spread through the air at a one-meter distance and cause infection in a new ferret model study.

16 Mar 2021

Cross-national study associates low vitamin D levels with higher COVID-19-related mortality

A new study by an international team of researchers – from New York University, Abu Dhabi, the Ludwig-Maximilians-Universität, München, and Barts Cancer Institute, London – showed that there are lower COVID-19 mortality rates in countries with the most insufficient annual sun exposure, but highest mean 25-hydroxyvitamin D (25(OH)D) or vitamin D (25)-HD levels.

16 Mar 2021

Janssen’s vaccine added to list of safe, effective tools against COVID-19

The World Health Organization (WHO) today listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European Medicines Agency (EMA) authorization, which was announced yesterday.

16 Mar 2021

New report calls for comprehensive smoke-free policies

A new WHO report, Tobacco Control To Improve Child Health And Development, calls for raising awareness among practitioners and policymakers about the importance of strong tobacco control measures for protecting the health and development of children, including banning tobacco advertising, implementing 100% smoke-free environments and raising taxes on tobacco.

16 Mar 2021

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

A new piece of research, published on the medRxiv preprint server, focused on the role of factors such as gender, age, hospitalization, etc., in understanding the risks of clinical sequelae in the post-acute phase of COVID-19, in adults aged between 18 and 65 years.

15 Mar 2021

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers from the US recently studied the prevalence of PASC in a well-characterized cohort of patients to gain insights into the period following acute SARS-CoV-2 infection. The research is posted online to the preprint server medRxiv.

15 Mar 2021

Upgrade Your Sample Management Workflow

Ziath has introduced an easy upgrade path for the many users of DataPaq 3 sample management software products to its powerful new DP5 suite of products.

From Ziath Ltd 15 Mar 2021

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

A new study describes a predictive model of protective immunity against SARS-CoV-2 infection that could help evolve optimal vaccination strategies to maintain protection and reduce the death rate.

15 Mar 2021

Which biomarkers can help predict severe COVID-19?

The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.

15 Mar 2021

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

Joan Phillips, a certified nursing assistant in a Florida nursing home, loved her job but dreaded the danger of going to work in the pandemic. When vaccines became available in December, she jumped at the chance to get one.

15 Mar 2021

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

Coronavirus disease (COVID-19) symptoms are increasingly recognized to persist among a subset of individuals following acute infection, but features associated with this persistence are not well-understood.

15 Mar 2021

Genome-wide CRISPR screening used to identify factors essential for SARS-CoV-2 infection in humans

In a methodologically trailblazing paper published in the journal Nature Genetics, a team of Belgian scientists uncovered an assembly of coronavirus host factors that may be exploited to develop drugs against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also potentially forthcoming zoonotic coronaviruses.

14 Mar 2021

New vaccination method aims at comprehensive protection against all known influenza mutations

One shot, protected forever: This would be a dream come true regarding influenza vaccinations. So far, vaccination against influenza did not provide a lasting protection.

13 Mar 2021

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

In asthma, the airways become hyperresponsive. Researchers from Uppsala University have found a new mechanism that contributes to, and explains, airway hyperresponsiveness.

13 Mar 2021

SARS-CoV-2 did not change much when it jumped from bats to human hosts

How much did SARS-CoV-2 need to change in order to adapt to its new human host? In a research article published in the open access journal PLOS Biology Oscar MacLean, Spyros Lytras at the University of Glasgow, and colleagues, show that since December 2019 and for the first 11 months of the SARS-CoV-2 pandemic there has been very little 'important' genetic change observed in the hundreds of thousands of sequenced virus genomes.

13 Mar 2021

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

In a study published in the journal Drugs, a researcher tackled the approval of Pfizer-BioNTech’s COVID-19 vaccine, which has now been used in many countries.

12 Mar 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Living with a COVID-19 case brings worse symptoms and stronger antibody response

SARS-CoV-2 can spread through cold-chain transport

Using iodine as catalyst to advance the sustainability of pharmaceutical syntheses

Combination therapy may reduce influenza-associated morbidity and mortality

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Cross-national study associates low vitamin D levels with higher COVID-19-related mortality

Janssen’s vaccine added to list of safe, effective tools against COVID-19

New report calls for comprehensive smoke-free policies

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Upgrade Your Sample Management Workflow

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

Which biomarkers can help predict severe COVID-19?

Covid cases plummet 83% among nursing home staffers despite vaccine hesitancy

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

Genome-wide CRISPR screening used to identify factors essential for SARS-CoV-2 infection in humans

New vaccination method aims at comprehensive protection against all known influenza mutations

Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma

SARS-CoV-2 did not change much when it jumped from bats to human hosts

An overview of the BNT162b2 COVID-19 vaccine by Pfizer-BioNTech

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in